Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News

Related or similar articles

October 9, 2024

A Fresh New Look at Labshares: Office Upgrade at 90 Bridge Street

Labshares News
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News
June 18, 2024

Labshares Announces Key Leadership Additions: Devon Lagasse Joins as VP of Growth and Emma Orfanos Is Promoted to Manager of Business Development

Press Releases